3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Brain Neoplasms
31
Carcinoma, Non-Small-Cell Lung
27
Prostatic Neoplasms
26
Lung Neoplasms
20
Neoplasm Metastasis
19
Melanoma
12
Breast Neoplasms
12
Pancreatic Neoplasms
8
Carcinoma, Renal Cell
8
Carcinoma, Hepatocellular
7
Small Cell Lung Carcinoma
5
Colorectal Neoplasms
5
Neoplasms
4
Urinary Bladder Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
NSCLC
3
Meningioma
3
Hematologic Neoplasms
3
Gastrointestinal Neoplasms
3
Uveal Melanoma
2
Unresectable Locally Recurrent Rectal Cancer
2
Thyroid Neoplasms
2
Sarcoma
2
Liver Neoplasms
2
Head and Neck Neoplasms
2
Carcinoma, Transitional Cell
2
Carcinoma, Merkel Cell
2
Adenocarcinoma
2
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Interventions
Cyclophosphamide
25
fludarabine
19
Dexamethasone
17
pembrolizumab
13
Rituximab
12
venetoclax
9
Lenalidomide
9
Gemcitabine
9
Etoposide
9
pomalidomide
8
Vincristine
7
glofitamab
6
fludarabine phosphate
6
carfilzomib
6
Temozolomide
6
obinutuzumab
5
daratumumab
5
Prednisone
5
Nivolumab
5
Doxorubicin
5
Cisplatin
5
Calcium Dobesilate
5
Bortezomib
5
zanubrutinib
4
selinexor
4
Immunotherapy, Adoptive
4
Cytarabine
4
Carboplatin
4
Azacitidine
4
ruxolitinib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
Radiosurgery
×
90 days
×
Clear all
No trials found.